From the President of Nagasaki University
Prof. KHONO Shigeru
This organizational reform will strengthen and streamline research on infectious diseases during regular times inside and outside the university. In an emergency such as a pandemic, we aim to rapidly develop vaccines and therapeutics from pathogen isolation and identification to clinical trials while also utilizing the BSL-4 facility. In addition, we aim to reform our organization into one capable of making policy recommendations in collaboration with the Interfaculty Initiative in Planetary Health by promoting deep collaboration with extramural research institutions and private companies. In the recent pandemic, Western countries could quickly commercialize vaccines and therapeutics through rapid research and development, but Japan lagged far behind. We hope the DIDA will play an essential role in future pandemics by strengthening collaboration both within and outside the university and with the world.